insights_auto
Why is SABS down 5,67%?
Dive Deeperchevron_right
SABS:NASDAQ
SAB Biotherapeutics Inc
2,74 $
arrow_downward
-5,67%(-0,17) 1D
20 қар., 12:40:23 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SABS...
Open
2,79 $
High
2,88 $
Low
2,64 $
Mkt. cap
247,29 млн
Avg. vol.
709,90 м.
Volume
213,70 м.
52-wk high
5,15 $
52-wk low
2,44 $
EPS
-0,93 $
Beta
0,67
Shares outstanding
90,09 млн
No. of employees
86
Open
2,79 $
High
2,88 $
Low
2,64 $
Mkt. cap
247,29 млн
Avg. vol.
709,90 м.
Volume
213,70 м.
52-wk high
5,15 $
52-wk low
2,44 $
EPS
-0,93 $
Beta
0,67
Shares outstanding
90,09 млн
No. of employees
86
News stories
From web sources and news partners
Los Angeles Times
·
12 минут бұрын
S&P 500 falls 10% from record, entering correction as AI trade unravels
WSJ
·
7 сағат бұрын
S&P 500 Flirts With Correction
Adam Feldman | Substack
·
23 сағат бұрын
Inside the Federal Litigation of Five S&P 500 Giants
Yahoo Finance
·
6 сағат бұрын
SPDR S&P 500 ETF (SPY) Sells Apple and Microsoft on Nov. 18
About SAB Biotherapeutics Inc
CEO-
Employees86
Founded2014
HeadquartersMiami Beach, Флорида, Америка Құрама Штаттары
SectorHealth Care
Industry-
Websitesab.bio